ES2157314T3 - Derivados triciclicos y su uso en productos farmaceuticos. - Google Patents
Derivados triciclicos y su uso en productos farmaceuticos.Info
- Publication number
- ES2157314T3 ES2157314T3 ES95903170T ES95903170T ES2157314T3 ES 2157314 T3 ES2157314 T3 ES 2157314T3 ES 95903170 T ES95903170 T ES 95903170T ES 95903170 T ES95903170 T ES 95903170T ES 2157314 T3 ES2157314 T3 ES 2157314T3
- Authority
- ES
- Spain
- Prior art keywords
- triciclic
- derivatives
- pharmaceutical products
- formula
- disclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Abstract
SE DESCRIBEN COMPUESTOS DE FORMULA (I), O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS. TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN COMPUESTOS DE FORMULA (I), METODOS PARA INHIBIR EL FACTOR {AL} DE NECROSIS POR TUMOR Y METODOS DE TRATAMIENTO DE CHOQUE SEPTICO, INFLAMACION O TRASTORNOS ALERGICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/162,748 US5464840A (en) | 1993-12-06 | 1993-12-06 | Tricyclic derivatives, compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2157314T3 true ES2157314T3 (es) | 2001-08-16 |
Family
ID=22586979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95903170T Expired - Lifetime ES2157314T3 (es) | 1993-12-06 | 1994-12-05 | Derivados triciclicos y su uso en productos farmaceuticos. |
Country Status (7)
Country | Link |
---|---|
US (2) | US5464840A (es) |
EP (1) | EP0733043B1 (es) |
JP (1) | JP2965357B2 (es) |
AT (1) | ATE202343T1 (es) |
DE (1) | DE69427542T2 (es) |
ES (1) | ES2157314T3 (es) |
WO (1) | WO1995015949A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
US5700806A (en) * | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
US5801175A (en) * | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
JP3779349B2 (ja) * | 1995-04-24 | 2006-05-24 | 興和株式会社 | ピペリジン誘導体 |
US6040305A (en) * | 1996-09-13 | 2000-03-21 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US5994364A (en) | 1996-09-13 | 1999-11-30 | Schering Corporation | Tricyclic antitumor farnesyl protein transferase inhibitors |
US5945429A (en) * | 1996-09-13 | 1999-08-31 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6071907A (en) * | 1996-09-13 | 2000-06-06 | Schering Corporation | Tricyclic compounds useful as FPT inhibitors |
US5861395A (en) * | 1996-09-13 | 1999-01-19 | Schering Corporation | Compounds useful for inhibition of farnesyl proteins transferase |
US6030982A (en) | 1996-09-13 | 2000-02-29 | Schering Corporationm | Compounds useful for inhibition of farnesyl protein transferase |
US5985879A (en) * | 1996-09-13 | 1999-11-16 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6130229A (en) * | 1996-10-09 | 2000-10-10 | Schering Corporation | Tricyclic compounds having activity as RAS-FPT inhibitors |
US6051582A (en) * | 1997-06-17 | 2000-04-18 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6218401B1 (en) | 1997-06-17 | 2001-04-17 | Schering Corporation | Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
US6576639B1 (en) | 1997-06-17 | 2003-06-10 | Schering Corporation | Compounds for the inhibition of farnesyl protein transferase |
US6228865B1 (en) | 1997-06-17 | 2001-05-08 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6211193B1 (en) | 1997-06-17 | 2001-04-03 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6239140B1 (en) | 1997-06-17 | 2001-05-29 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6159984A (en) | 1997-06-17 | 2000-12-12 | Schering Corporation | Farnesyl protein transferase inhibitors |
US6689789B2 (en) | 1997-06-17 | 2004-02-10 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
US6316462B1 (en) * | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
NZ568694A (en) | 2005-11-09 | 2011-09-30 | Zalicus Inc | Method, compositions, and kits for the treatment of medical conditions |
US8118976B2 (en) * | 2007-05-23 | 2012-02-21 | Akzo Nobel N.V. | Process for the production of a cellulosic product |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985660A (en) * | 1960-04-29 | 1961-05-23 | Lakeside Lab Inc | 5-heterocyclic-5h-dibenzo [a, d] cycloheptenes |
US3922305A (en) * | 1962-08-09 | 1975-11-25 | Merck & Co Inc | Chemical compounds |
NL132137C (es) * | 1963-04-24 | |||
SE331992B (es) * | 1963-07-25 | 1971-01-25 | Merck & Co Inc | |
US3981917A (en) * | 1963-07-25 | 1976-09-21 | Merck & Co., Inc. | Chemical compounds |
US3978121A (en) * | 1963-07-25 | 1976-08-31 | Merck & Co., Inc. | 5H Dibenzo[a,d]cycloheptene derivatives |
FR92375E (fr) * | 1966-02-04 | 1968-10-31 | Rhone Poulenc Sa | Nouveaux dérivés du dibenzocycloheptatriène et leur préparation |
NL130988C (es) * | 1966-07-21 | Boehringer Mannheim Gmbh | ||
GB1274263A (en) * | 1968-05-03 | 1972-05-17 | Hoffmann La Roche | Dibenzocycloheptene derivatives |
US3595865A (en) * | 1968-09-12 | 1971-07-27 | Searle & Co | 5-(4-pyridyl)-5h-dibenzo(a,b)cycloheptenes |
DE2335943C3 (de) * | 1973-07-14 | 1979-08-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Tricyclisch substituierte Aminoalkohole und ihre nichttoxischen Salze, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von Herz- und Kreislauferkrankungen |
US4626542A (en) * | 1984-04-05 | 1986-12-02 | Merck & Co., Inc. | 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmaceutical compositions and methods |
US4758577A (en) * | 1984-04-05 | 1988-07-19 | Merck & Co., Inc. | 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders |
US4826853A (en) * | 1986-10-31 | 1989-05-02 | Schering Corporation | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
US5438062A (en) * | 1986-10-31 | 1995-08-01 | Schering Corporation | Benzo(5,6)cycloheptapyridines, compositions and methods of use |
US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
EP0339978B1 (en) * | 1988-04-28 | 1996-08-21 | Schering Corporation | Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents |
US5104876A (en) * | 1988-04-28 | 1992-04-14 | Schering Corporation | Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use |
EP0411048A1 (en) * | 1988-04-28 | 1991-02-06 | Schering Corporation | Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use |
US4863931A (en) * | 1988-09-15 | 1989-09-05 | Schering Corporation | Antihistaminic fluoro substituted benzocycloheptapyridines |
US4996321A (en) * | 1990-02-26 | 1991-02-26 | Merck & Co., Inc. | Dibenzo[a,d]cycloheptenylidene compounds |
JPH06504772A (ja) * | 1990-12-18 | 1994-06-02 | ザ ウエルカム ファウンデーション リミテッド | 抗癌剤の薬効を増強し抗多剤耐性を有する薬剤 |
AU2028892A (en) * | 1991-05-23 | 1992-12-30 | Schering Corporation | Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
EP0524784A1 (en) * | 1991-07-23 | 1993-01-27 | Schering Corporation | Benzopyrido piperidylidene compounds as PAF antagonists |
-
1993
- 1993-12-06 US US08/162,748 patent/US5464840A/en not_active Expired - Fee Related
-
1994
- 1994-12-05 JP JP7516224A patent/JP2965357B2/ja not_active Expired - Fee Related
- 1994-12-05 EP EP95903170A patent/EP0733043B1/en not_active Expired - Lifetime
- 1994-12-05 DE DE69427542T patent/DE69427542T2/de not_active Expired - Fee Related
- 1994-12-05 WO PCT/US1994/013663 patent/WO1995015949A1/en active IP Right Grant
- 1994-12-05 ES ES95903170T patent/ES2157314T3/es not_active Expired - Lifetime
- 1994-12-05 AT AT95903170T patent/ATE202343T1/de not_active IP Right Cessation
-
1995
- 1995-06-02 US US08/458,581 patent/US5688805A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5688805A (en) | 1997-11-18 |
ATE202343T1 (de) | 2001-07-15 |
US5464840A (en) | 1995-11-07 |
EP0733043B1 (en) | 2001-06-20 |
JP2965357B2 (ja) | 1999-10-18 |
DE69427542D1 (de) | 2001-07-26 |
JPH09500657A (ja) | 1997-01-21 |
EP0733043A1 (en) | 1996-09-25 |
WO1995015949A1 (en) | 1995-06-15 |
DE69427542T2 (de) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2157314T3 (es) | Derivados triciclicos y su uso en productos farmaceuticos. | |
ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
DK0889875T3 (da) | Cycloproylalkansyrederivater | |
NO306346B1 (no) | N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
ES2166823T3 (es) | Nuevos derivados pirrolicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
RU94044436A (ru) | Способы подавления атрофии кожи и влагалища | |
KR950700309A (ko) | 피페리디닐 티아시클릭 유도체(Piperidinyl Thiacyclic Derivatives) | |
DE69413237T2 (de) | Plättchenaggregationsinhibitoren | |
MX9204637A (es) | Nuevos derivados de pirazina y procedimiento para su preparacion. | |
ES2160602T3 (es) | Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria. | |
ES2154669T3 (es) | Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago. | |
ES2128701T3 (es) | Derivados triciclicos y su uso en productos farmaceuticos. | |
KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
DK0733035T3 (da) | Tricykliske derivater og farmaceutiske præparater, der indeholder dem | |
DE69330601T2 (de) | Serotoninergische ergolin derivate | |
DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
AP9801235A0 (en) | Erythromycin derivatives. | |
DE69318715D1 (de) | Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate | |
IL115016A (en) | Benzothiophene derivatives for bone healing and fracture repair pharmaceutical compositions comprising same and uses thereof | |
FI961423A0 (fi) | Antrasykliinidisakkaridit, menetelmä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostumukset | |
ES2155895T3 (es) | Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la hiperplasia endometrial primaria. | |
RU93058386A (ru) | Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 733043 Country of ref document: ES |